To investigate if hepatocyte FGF21 was directly involved in the improvement of obesity, AlbCre-Fgf21 and their control mice (AlbCre) were fed a HFD and were treated with Mat1a or control ASO from the sixth week of the HFD. Here, FGF21 is linked to obesity disorder.